These are genuinely different molecular targets engaging different intracellular signaling
sperm and testis were harvested at 30.5 weeks
Important upfront: in the Western pharmaceutical world BPC-157 never passed Phase 3 trials (= the large clinical trials required before drug approval)
More precisely, among them, the cyclin-dependent kinase inhibitor p21 Cip1/WAF1 , induced by p53 in response to OS and involved in the regulation of cell cycle arrest, replication, cellular proliferation, and apoptosis, competes with KEAP1 for the binding to NRF2 through the DLG motif, thus preventing NRF2 ubiquitination, and increasing its stabilization [184, 185]
This article covers the biological rationale for nocturnal timing, what happens when you inject at suboptimal times, and how to structure administration around real-world constraints like shift work or fasting protocols